UNSPSC 51434959: Indapamide/Perindopril arginine

It is an antihypertensive and is used in the treatment of high blood pressure (hypertension).

UNSPSC 51434959 Indapamide/Perindopril arginine is a Commodity code representing a specific pharmaceutical combination product. The recent state and local procurement record shows no solicitations actually purchasing this drug formulation; the opportunities posted under this code are administrative notices, vendor networking events, and procurements for unrelated pharmaceutical products and services that have been incorrectly tagged or lack substantive scope alignment with the code's nominal meaning. A notice from Williamson County on an office relocation, a vendor trade show and business development forums across multiple Florida and Texas jurisdictions, and a Seminole County procurement for naloxone and drug deactivation systems do not reflect active demand for indapamide/perindopril combination therapy in state and local health systems.

The one pharmaceutical procurement clearly visible—the City of Tucson Fire Department's RFP for BLS/ALS pharmaceuticals and supplies issued in June 2026 with a response deadline of June 24, 2026—covers a broad range of emergency medical supply items, from glucometers and IV administration sets to suction equipment and diagnostic devices, without naming indapamide/perindopril specifically. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, similarly establishes a multi-state contract mechanism but does not identify this specific combination agent in its scope. No state departments, county health agencies, municipal fire or EMS services, school districts, or transit authorities show recent activity purchasing indapamide/perindopril through formal solicitation under this code. The geographic spread of posted opportunities—Texas, Florida, Arizona, and Minnesota—reflects general pharmaceutical and medical supply procurement activity, not targeted demand for this particular formulation. Until state and local agencies post RFPs, RFQs, or IFBs explicitly naming indapamide/perindopril in their scope, this code warrants close monitoring rather than active pursuit.